GFAP and early-onset autosomal dominant Alzheimer disease: The latest research shows that berberine significantly decreases the expression of GFAP in the Alzheimer’s disease mice hippocampus, indicating berberine inhibits the overexpression of astrocytes in Alzheimer’s disease mice.